Study: no link between cannabis and cardiovascular disease
A U.S. study has just to debunk a widespread belief. In fact, it found no link between cannabis use and the onset of cardiovascular diseases—those affecting the heart and blood vessels. This large-scale study, conducted among more than 56,000 American adults, was published by the journal Cureus Journal of Medical Science.
«Although the scientific literature has has been shown in the past that cannabis has a negative impact on cardiovascular health, », our study shows that cannabis use is not associated with the incidence of cardiovascular disease", note the six authors of this study. To shed light on the scientific debate, they emphasize «the need for further research on this link» the link between cannabis and heart disease.
To reach this conclusion, scientists analyzed the massive U.S. health database. Known as the Behavioral Risk Factor Surveillance System (BRFSS), this database contains all health data on Americans. It is managed by the Centers for Disease Control and Prevention, which is the equivalent of Santé Publique France in France.
The scientists included only patients over the age of 18 who had provided information about their cannabis use and cardiovascular diseases. The researchers also note: «Age, gender, ethnicity, body mass index, income, physical activity, tobacco and alcohol use, and depression were all accounted for as potential confounding variables.»
Accounts for 0.8 % of heart attacks
This new study contradicts other studies that have linked cannabis to cardiovascular disease. One such study, conducted in 2014, led by a French female doctor. Émilie Jouanjus, Ph.D. in pharmacology at Toulouse University Hospital, stated to the Sunday Journal : «While reviewing the medical records of 200 patients hospitalized in Toulouse between 2004 and 2007, I was struck by the occurrence of heart attacks or strokes in young men, between the ages of 22 and 26, with no other specific risk factors aside from cannabis use.»
However, this study has a major methodological bias: the sample consists solely of hospitalized young people. These individuals are therefore already in poor health. In fact, Emilie Jouanjus qualified the findings of her research: «This study does not allow us to conclude that smoking cannabis increases cardiovascular risk compared to smoking cigarettes alone, but other studies do show this.»
In fact, Dr. Jouanjus’s study was not the only one. In 2011, another American study published in the prestigious British journal The Lancet supported her position. She claimed that cannabis could account for 0.8 % of non-fatal heart attacks. However, this rate—which is relatively low—is lower than the risk associated with exposure to pollution (7 % of heart attack cases) or coffee consumption (5 %).
-
Cannabis in Europe4 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France3 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.4 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Business3 weeks ago
China Invests $10 Million in Medical Cannabis in Lebanon
-
Cannabis in Thailand4 weeks ago
Thailand Threatens Cannabis Shops with Severe Penalties
-
Business4 weeks ago
The British medical cannabis market is expected to exceed 140,000 patients by 2026
-
Cannabis in Australia2 weeks ago
South Australia is working to identify more water-efficient hemp varieties
-
Exchange4 weeks ago
Glass House will be the second U.S. cannabis company to list on the New York Stock Exchange


You must be logged in to post a comment Login